Vir Biotechnology’s elebsiran and tobevibart duo hits key phase 3 trial milestone, with 44% of...
A 2024 study in Frontiers in Oncology finds 15-20% endometrial cancer recurrence risk after treatment,...
Experts explain how patients and care teams can adapt after a myeloma relapse, addressing treatment...
New drugs target root cause of mastocytosis, offering hope for patients with systemic mastocytosis.
Patients with polycythemia vera continue experiencing symptoms despite treatment, impacting daily life. Learn why symptoms...
People who are marginalized or lack access to a primary care provider face a higher...
New research reveals prenatal depression therapy shapes infant brain growth and emotional responses, showing the...
Rhode Island insurers approved a 12.4% average health premium hike in 2027, affecting 50,700 people...
Ground cinnamon product recalled due to high lead levels found in testing, affecting six states...
AI coding dispute where insurers blame rising costs on AI tools flagging complex diagnoses, while...